US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Oxycodone Hydrochloride Oral Solution

Reason Presence of Foreign Substance: Particulate matter was found in multiple lots of product.

Genus Lifesciences Inc. NDC 64950-354-05 D-0231-2021
Class III · Low risk Terminated

Epinephrine/Lidocaine HCl

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

Edge Pharma, LLC NDC 05446-0863-01 D-0307-2021
Class III · Low risk Terminated

Benzhydrocodone and Acetaminophen Tablets

Reason Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A

KVK-Tech, Inc. NDC 10702-344-01 D-0224-2021
Class III · Low risk Terminated

Succinylcholine Chloride PF Inj. 200 mg/10 mL

Reason Labeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible.

US Compounding Inc D-0223-2021
Class III · Low risk Terminated

Fentanyl

Reason Subpotency: Out-of-specification stability test result for low potency was obtained.

SCA Pharmaceuticals D-0147-2021
Class III · Low risk Terminated

Scandonest 3% Plain

Reason Labeling: Label mix-up

Novocol Pharmaceutical of Canada, Inc. NDC 0362-1098-90 D-0127-2021
Class III · Low risk Terminated

DOXOrubicin Hydrochloride Injection

Reason Cross Contamination with Other Products: trace amounts of octreotide found during testing

Fresenius Kabi USA, LLC D-0105-2021
Class III · Low risk Terminated

Levocetirizine Dihydrochloride Tablets

Reason Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.

InvaTech Pharma Solutions, LLC NDC 10135-0639-30 D-0115-2021
Class III · Low risk Terminated

Testosterone Gel 1%

Reason Superpotent Drug: High out-of-specification assay results were obtained during stability testing.

Teva Pharmaceuticals USA NDC 0591-3216-17 D-0100-2021
Class III · Low risk Terminated

Triamcinolone Acetonide Lotion USP

Reason Subpotent Drug: One lot of Triamcinolone Acetonide Lotion, 0.025% 60 mL.does not meet assay results.

Teligent Pharma, Inc. NDC 52565-010-59 D-0110-2021
Class III · Low risk Terminated

Felodipine Extended Release Tablets

Reason Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for the impurity Felodipine Related compound A

Heritage Pharmaceuticals Inc NDC 23155-050-01 D-0108-2021
Class III · Low risk Terminated

Dextroamphetamine Saccharate

Reason Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

ANI Pharmaceuticals, Inc. NDC 43975-282-10 D-0048-2021
Class III · Low risk Terminated

Dextroamphetamine Saccharate

Reason Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

ANI Pharmaceuticals, Inc. NDC 43975-281-10 D-0047-2021
Class III · Low risk Terminated

Dextroamphetamine Saccharate

Reason Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

ANI Pharmaceuticals, Inc. NDC 43975-280-10 D-0046-2021
Class III · Low risk Terminated

Dextroamphetamine Saccharate

Reason Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

ANI Pharmaceuticals, Inc. NDC 43975-279-10 D-0045-2021
Class III · Low risk Terminated

Dextroamphetamine Saccharate

Reason Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

ANI Pharmaceuticals, Inc. NDC 43975-278-10 D-0044-2021
Class III · Low risk Terminated

Dextroamphetamine Saccharate

Reason Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

ANI Pharmaceuticals, Inc. NDC 43975-277-10 D-0043-2021
Class III · Low risk Terminated

Desflurane

Reason DEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.

eVenus Pharmaceutical Laboratories NDC 0781-6172-22 D-0042-2021